There are outstanding studies on the importance of survivin and inhibition of apoptosis in many cancers, including lung. Evaluation of the relationship between survivin expression in lung cancer and prognosis is the aim of this study. A total of 50 patients with a diagnosis of squamous cell lung carcinoma were included in this study. Survivin levels that were obtained with IHC (immunohistochemical) and RT-PCR (reverse transcription-polymerase chain reaction) methods from the tumor and metastatic lymph node tissues embedded in paraffin blocks were evaluated along with clinical parameters. The median age of the patients was 60 years (range 54-69). All patients were male and all of them were smokers. The mean duration of follow-up and disease-free survival was 42.08±22.46 months and 40.62±22.46 months, respectively. Significant associations were found among survivin levels in metastatic lymph nodes and duration of smoking (IHC and RT-PCR), angiolymphatic invasion (IHC), the number of mitosis (RT-PCR) ( p= 0.05 and p= 0.05, p< 0.001, p= 0.02, respectively). Survivin showed statistically significant associations with angiolymphatic invasion and stage in multivariate analysis (p< 0.001, p= 0.04, respectively). An association was not found between survivin levels in tumor and lymph nodes and survival. Higher survivin levels in lymph nodes detected by IHC was associated with shorter survival but that didn't reach statistical significance (65.22±5.16 vs 42.33±11.97, p= 0.72). Further larger studies done with larger numbers of patients are required in order to evaluate its effects in our society. 
INTRODUCTION
Lung cancer consists 12% of all cases of cancer globally. It occupies the second place among causes of cancer-related deaths in males and females. 1, 2 Smoking is the most important etiologic factor in the development of lung cancer. The risk of lung cancer is 20 times higher in smokers in comparison to non-smokers. Age to start smoking, total duration of smoking, total number of cigarettes smoked, are all effective on the risk. 3 Recently, some targets related to adenocarcinoma subtype were detected and drugs targeting them were developed, but for squamous cell carcinoma until now there is no such type of specific target. The first line of therapy for this histological type is chemotherapy. Studies on determination of biomarkers for predicting prognosis and response to chemotherapy have increased recently.
Apoptosis is a process which is important in both carcinogenesis and cancer treatment. [4] [5] [6] There are outstanding studies on the importance of survivin and inhibition of apoptosis in many cancers, including breast, lung, esophagus, stomach, headneck, and cervix. [7] [8] [9] [10] [11] Survivin is a protein which is made up of 142 amino acids of 16.5 kD, and is an apoptosis inhibitor. It is the smallest member of IAP (inhibitor apoptotic protein) family in mammals. 12 According to some studies surviving may act as a target for cancer treatment and as a prognostic marker. [13] [14] There is no data on the literature evaluating the correlation between survivin in squamous cell subtype and clinicopathological parameters and survival. There are recent notable studies evaluating the relationship between especially response to chemotherapy, EGFR resistance and surviving. [15] [16] [17] [18] In this study, the relationship between survivin in both tumor and metastatic lymph nodes and clinicopathological parameters and survival in patients with squamous cell non-small cell lung cancer, which is more frequently seen in our country were evaluated. The study was approved by the Ethics Committee of Pamukkale University and scientific investigation project.
PATIENTS AND METHODS
A total of 50 patients with squamous cell lung carcinoma, stages between 1-3, who had undergone pneumonectomy, lobectomy, or wedge resection, who had not received neoadjuvant chemotherapy or radiotherapy, treated and followed-up by the Pamukkale University Medical School Department of Medical Oncology between the years 2005-2013 were examined retrospectively. The demographic data of the patients, tumor types, chemotherapies received were extracted from the patient files. The patients were detected from the patient follow-up files of Outpatient Clinics of Medical Oncology, and the stages, duration of survival were examined statistically at the end of study.
Determination of survivin expression with IHC method: The diagnosis of lung carcinoma, tumor differentiation in the histological sections of resection materials, and the presence of metastatic lymph node in lymph node dissection materials were reexamined and re-evaluated. The samples that best reflected the tumor tissue were selected. Five 3 micron sections were taken for the purpose of survivin antibody examination to positive -charged glasses from selected paraffin blocks for each case. The tissue samples were left at 50 0 C for one night in the incubator for deparaffination. They were later dyed automatically with the help of VENTANA, Benchmark LT device. In sections dyed automatically, 1/200 diluted survivin antibody (Anti-BIRC5 policlonal rabbit antibody, BiOSs, Woburn, USA) was used and the targeted proteins were visualized. The duration of incubation with antibodies was 36 minutes for survivin. After which, it was held in 70% alcohol for 2 minutes, in 80% alcohol for 2 minutes, in 95 % alcohol for 2 minutes and absolute alcohol for 2 minutes, sequentially. The sections were dried in the air and held in Xylene for 15 minutes, and closed with entellan.
Survivin expression was determined in the cytoplasm. Cytoplasmic staining was considered positive for survivin, and other staining were considered negative in the evaluation. Cytoplasmic survivin staining was recorded in between 0-100 % according to diffusiveness. Staining of 50% and more of the cells was considered as an increased survivin expression (Picture 1).
Determination of survivin expression with RT-PCR method: Both tumor tissues of patients and also 10 µm sections of lymph nodes in terms of distant or-International Journal of Hematology and Oncology gan metastasis were transported to sterile ependorf tubes. These were incubated at 56° C for 20 minutes with xylene in order to remove paraffin from these tissues. Afterwards, paraffin was removed by centrifugation at 14000xg for 2 minutes. After this procedure, xylene was removed with use of 96% absolute alcohol. After centrifugation at 14000 xg for 2 minutes, the supernatant was removed. The pellet was incubated at 56°C for 15 minutes for evaporation of alcohol from the environment. Then, RNA was isolated with use of qiagen FFPE isolation (kat:73504 Germany) kit. The RNA thus obtained was measured with a nanodrop and was stored at -80°C. After total RNA levels of all patients were obtained, total RNAs were turned into cDNA with the help of qiagen cDNA (Kat:679923 France) synthesis kit. The protocol was as follows; 5x tampon 5µl, dNTP 100 nM, random nanomer 5,2 µl, reverse transcriptase 1 µl, DTT 1,25 µl, RNAse inhibitor 0,5µl, sample 10 µl reaction complex were prepared. cDNA was obtained after incubations at 65 
Statistical Analysis
SPSS version 17 was used in the statistical analysis. Descriptive statistics were presented as mean, standard deviation and percent. Significance of differences between the groups was evaluated International Journal of Hematology and Oncology with Mann-Whitney U test. Associations between quantitative data were determined with the help of Spearman correlation test. Progression-free and overall survival was calculated with KaplanMeier. Log-rank was used for statistical significance and p< 0.05 was considered as statistically significant. In evaluation of tumor and lymph node survivin levels in multivariate analysis, linear regression was used and cox regression analysis was used for evaluation of survival duration.
RESULTS
The median age of 50 patients included in this study was 60 years (range, 54-69). All of the patients were males and all had a history of past smoking. Twenty-two (44%) patients had received adjuvant chemotherapy, 3 patients (6%) had adjuvant radiotherapy. Twenty nine patients had undergone (58%) lobectomy, 20 had undergone pneumonectomy (40%), 1 patient (2%) had undergone wedge resection. In histopathological examination, 12 of the patients had poor differentiated morphology, whereas 38 showed moderatewell differentiation. The tumor diameter was 1 cm at its smallest point, and 10 cm at its largest, with a mean value of 4.01±2.09 cm. The tumor had a central location in 33 (66%) patients, and peripheral location in 17 (34%) patients. In histopathological examination, the mean number of mitosis in the tumor was 7 (range, 4-10). Of the patients, 28 (56.0%) had angiolymphatic invasion, and 21 (42%) had lymph node metastasis. Forty-five patients (90%) were at stage 1 and 2, 5 patients (10%) were at stage 3. The mean duration of follow-up was 42.08±20.68 months in 50 patients. The mean disease-free duration of survival of the patients was 40.62±22.46 months, and the general duration of survival was 42.08±20.68 months. The histopathological characteristics of the patients are presented in Table 1 . The mean survivin level in the tumor was 74.70±27.30 with IHC method; and As it is shown in Table 2 , significant associations were found between survivin levels in metastatic lymph nodes and the duration of smoking (IHC and RT-PCR), angiolymphatic invasion (IHC) and the number of mitosis (RT-PCR) ( p= 0.05 and p= 0.05, p< 0.001, p= 0.02, respectively). There was a significant association between angiolymphatic invasion and stage with survivin levels in multivariate analysis (p< 0.001, p= 0.04, respectively). In survivin levels which were found to be increased in the lymph node with IHC, OS was shorter but it did not reach statistical significance (65.22±5.16 vs 42.33±11.97, p= 0.72). An association was not found between survivin levels in the tumor and lymph node and OS (Figure 1 and 2) . Only lymph node metastasis were significantly correlated with OS in multivariate analysis (p= 0.001) ( Tables 3, 4) . 
DISCUSSION
Survivin is expressed in embrionic cells and malignant cells, but it is not expressed in mature-differentiated cells. 19 The relationship between survivin, which is an anti-apoptotic protein, and a number of cancers were documented. It may show different functions according to the locations. Survivin, which is a member of IAP family inhibits apoptosis by inhibiting caspase 3 and 7. 20 When the level of expression is evaluated, more survivin expression was reported in the study by Falleni et al. in patients with squamous cell lung cancer in comparison with adenocarcinoma and large cell subtypes. 21 In the studies by Sun, Huang no differences in expression were found between histological subtypes. 22, 23 Its prognostic value was assessed but clinicopathological correlations were not examined in any studies. [24] [25] [26] [27] [28] [29] [30] In terms of data on its prognostic significance, there are studies in which it was found to be a marker of poor prognosis, while there are other studies which have found the contrary. [25] [26] [27] Also, there are no studies in the literature investigating the relationship between metastatic lymph node and clinical characteristics and survival in squamous cell subtype. Small groups of patients with squamous cell and adenocarcinoma were examined in these studies. A total of 225 patients with adenocarcinoma and 148 patients with squamous cell carcinoma were evaluated in the study by Sun et al, which may be considered as the most extensive investigation, and prognostic significance was not found in patients with squamous cell carcinoma. 22 There are no studies in which metastasis was investigated along with the tumor tissue. According to our study, it may be stated that it is one of the factors that contribute to progression. In terms of survival, the inverse relationship between survivin levels and survival in lymph node metastasis may provide an important clue for us, although it did not reach statistical significance. Along with data showing that survivin m-RNA levels may be effective in predicting response to anti-EGFR agents, there is also data that it may be effective in over- It is also not clear how survivin levels should be evaluated. In a literature evaluation, values between 10-50% were found to be reported in studies with IHC method. 32 Furthermore, the threshold value with PCR method in the literature is different in each study. 33, 34 A correlation between IHC and RT-PCR was not found in our study. But a conclusion may be reached with large-scale studies evaluating both methods together.
When racial differences are considered, it is hard to reach a conclusion, as there are no studies evaluating the relationship between survivin and squamous cell lung cancer in our society. Another important problem preventing conclusions in other racial groups is the larger number of studies on Asian populations.
The limitations of our study include the absence of control groups, the small sample size. Limitations in labour and economic conditions prevented us to overcome these limitations.
CONCLUSION
Survivin expression increases during the metastatic process and shows a negative correlation with OS. Higher survivin levels in lymph nodes detected by IHC were associated with shorter survival. An association was not found between survivin levels in tumor and lymph nodes and survival. Further larger studies done with larger numbers of patients are required in order to evaluate its effects in our society. Due to heterogeneity in the studies, more homogenous data are needed to assess survivin in squamous lung cancer. Also, combinations with targeted agents and immunotherapy may contribute in the prevention of resistance, and we believe that detailed investigations on this issue in the future may provide an effective strategy in increasing the probability of cure.
